Welcome To The China Medical Technologies, Inc. HUB China Securities
Non-GAAP adjusted income from continuing operation, as defined below, increased by 94.5% year-over-year to RMB119.4 million (US$17.5 million)
Message: China Medical Technologies to Announce Unaudited Financial Results
Rank: [?]
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

China Medical Technologies to Announce Unaudited Financial Results

posted on Feb 08, 10 08:00AM

BEIJING, Feb. 8 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leadingChina-based advanced in-vitro diagnostic ("IVD") company, today announced that it will report its unaudited financial results for the third fiscal quarter ended December 31, 2009 ("3Q FY2009") before the U.S. market opens on March 3, 2010. The Company's 2009 fiscal year ends on March 31, 2010.

The Company's senior management will host an earnings conference call at 8:00 a.m. U.S. Eastern Time on March 3, 2010(9:00 p.m. Beijing/Hong Kong time on March 3, 2010).

    Conference Call
                      The dial-in details for the live conference call are as follows:
                      -- U.S. Toll Free Number 1-866-713-8562
                      -- International Dial-in Number 1-617-597-5310
                      Passcode: CMEDCALL

A live webcast of the conference call will be available on http://ir.chinameditech.... .

A replay of this webcast will be available for one month on this website.

A telephone replay of the call will be available after the conclusion of the conference call through 10:00 a.m.U.S. Eastern Time on March 4, 2010. The dial-in details for the replay are as follows:

    -- U.S. Toll Free Number 1-888-286-8010
                      -- International Dial-in Number 1-617-801-6888
                      Passcode: 33530003

About China Medical Technologies, Inc.

China Medical Technologies, Inc. is a leading China-based advanced IVD company using Fluorescent in situ Hybridization (FISH) technology, Surface Plasmon Resonance (SPR) technology and Enhanced Chemiluminescence Immunoassay (ECLIA) technology to develop, manufacture and distribute diagnostic products for detecting and monitoring various cancers, diseases and disorders. For more information, please visit http://www.chinameditech... .

    For more information, please contact:
                       Winnie Yam
                       Phone: +852-2511-9808
                       Email: IR@chinameditech.com

New Message

Please login to post a reply

Executive Address
Cmed - small
China Medical Technologies, Inc.
Welcome to Chinasecurities
March 09, 2009
Stock Quote
Hub Leaders